(Q40418399)

English

Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

author name string

C Olivier

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

B H Belohradsky

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

S Stojanov

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

E Bonnet

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

G Petersen

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

J G Liese

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

6 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

3142-3152

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

The epidemiology of pneumococcal disease in infants and children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Epidemiology of invasive streptococcus pneumoniae infections in children in Spain, 1996-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

[Clinical effectiveness of seven-valent pneumococcal conjugate vaccine (Prevenar) against invasive pneumococcal diseases: prospects for children in France]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Invasive pneumococcal disease in England and Wales: vaccination implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Paediatric, invasive pneumococcal disease in Switzerland, 1985-1994. Swiss Pneumococcal Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Outcomes of bacterial meningitis in children: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Seroimmunity following vaccination in infants by an inactivated poliovirus vaccine prepared on Vero cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

[The safety and immunogenicity of an heptavalent pneumococcal polysaccharide conjugate vaccine (Prevenar) administered in association with a whole-cell pertussis-based pediatric combination vaccine (DTP-IPV/PRP-T) to French infants with a two-, thre

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

Epidemiology of pneumococcal infections in Swedish children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.096

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.11.096

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40418399&oldid=1897301228"